LC analysis and pharmacokinetic study of pachymic acid after intravenous administration to rats

被引:7
作者
Alatengqimuge, Yue [1 ]
Yang, Xiu-Wei [1 ]
Zheng, Yan [1 ]
Ma, Lian [1 ]
Lu, Wei [2 ]
机构
[1] Peking Univ, State Key Lab Nat & Biomimet Drugs, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
[2] Peking Univ, Dept Pharmaceut, Sch Pharmaceut Sci, Beijing 100083, Peoples R China
基金
国家高技术研究发展计划(863计划); 中国博士后科学基金; 中国国家自然科学基金;
关键词
column liquid chromatography; pharmacokinetics; rat plasma; pachymic acid;
D O I
10.1365/s10337-008-0577-7
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple and sensitive high-performance liquid chromatographic method with UV detection was developed and validated to investigate the concentration of pachymic acid (PA) in rat plasma. The sample preparation was a liquid-liquid extraction and chromatographic separation was achieved with a Dikma Diamonsil (TM) C(18) column (250 x 4.6 mm I.D.) with a C(18) guard column (8 x 4 mm I.D.) using a mobile phase consisting of MeOH-MeCN-aq. 0.45% H(3)PO(4) (45:40:22) at a flow rate of 1.0 mL min(-1). The UV detection was at 210 nm. Standard curves were linear (r = 0.9998) in plasma over the concentration range of 0.5-50 mu g mL(-1) and had acceptable accuracy and precision. Intra- and inter-day precisions expressed as the relative standard deviation (RSD) were 0.26-1.60% and 1.24-2.31%. The lower limit of quantification and lower limit of detection were 0.45 and 0.17 mu g mL(-1). The method has been used successfully to study the pharmacokinetics of PA. After a dose of 30 mg kg(-1) by intravenous administration, the main pharmacokinetic parameters t(1/2), AUC(0-infinity), CL, V(ss) and MRT(0-infinity) were 8.79 +/- 6.80 h, 18.90 +/- 9.39 mu g h mL(-1), 0.53 +/- 0.28 L h(-1), 5.60 +/- 4.60 L and 12.58 +/- 9.95 h, respectively.
引用
收藏
页码:807 / 811
页数:5
相关论文
共 14 条
[1]   NONCOMPARTMENTAL DETERMINATION OF THE STEADY-STATE VOLUME OF DISTRIBUTION [J].
BENET, LZ ;
GALEAZZI, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (08) :1071-1074
[2]   Two fungal lanostane derivatives as phospholipase A(2) inhibitors [J].
Cuellar, MJ ;
Giner, RM ;
Recio, MC ;
Just, MJ ;
Manez, S ;
Rios, JL .
JOURNAL OF NATURAL PRODUCTS, 1996, 59 (10) :977-979
[3]  
DAVIS B, 1992, PHARM RES, V10, P1093
[4]  
Ding Gang, 2002, Zhongguo Zhongyao Zazhi, V27, P756
[5]   Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos [J].
Gapter, L ;
Wang, ZS ;
Glinski, J ;
Ng, KY .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (04) :1153-1161
[6]   In vivo studies on the anti-inflammatory activity of pachymic and dehydrotumulosic acids [J].
Giner, EM ;
Máñez, S ;
Recio, MC ;
Giner, RM ;
Cerdá-Nicolás, M ;
Ríos, JL .
PLANTA MEDICA, 2000, 66 (03) :221-227
[7]  
Kaminaga T, 1996, ONCOLOGY, V53, P382
[8]   Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos [J].
Li, G ;
Xu, ML ;
Lee, CS ;
Woo, MH ;
Chang, HW ;
Son, JK .
ARCHIVES OF PHARMACAL RESEARCH, 2004, 27 (08) :829-833
[9]   Pharmacokinetics of E-6087, a new anti-inflammatory agent, in rats and dogs [J].
Reinoso, RF ;
Farrán, R ;
Moragón, T ;
García-Soret, A ;
Martínez, L .
BIOPHARMACEUTICS & DRUG DISPOSITION, 2001, 22 (06) :231-242
[10]   Inhibitory effects of triterpenes isolated from Hoelen on free radical-induced lysis of red blood cells [J].
Sekiya, N ;
Goto, H ;
Shimada, Y ;
Endo, Y ;
Sakakibara, I ;
Terasawa, K .
PHYTOTHERAPY RESEARCH, 2003, 17 (02) :160-162